Uveal melanoma in a patient with neurofibromatosis

Article Sidebar

Article Details

Authors

Susan Dominguez
Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala, Guatemala.
José Dominguez
Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala, Guatemala.

Publication Information

DOI:   https://doi.org/10.36109/rmg.v160i3.393
Published:   Dec 5, 2021
Issue:   Vol. 160 No. 3: September - December, 2021
Section:   Case Report

Keywords

melanoma
uvea
neurofibromatosis
Guatemala

Abstract

The most common malignant primary intraocular tumor in adults is uveal melanoma, constituting 5% of all melanomas, with a mortality rate of 33%. Neurofibromatosis type 1 occurs in 0.03% of the general population and is associated with melanoma in up to 66% of cases. The case of a male patient with uveal melanoma and a history of neurofibromatosis is presented.

Graph - Number of readers per month

Downloads

Download data is not yet available.

How to Cite

1.
Dominguez S, Dominguez J. Uveal melanoma in a patient with neurofibromatosis. Rev. méd. (Col. Méd. Cir. Guatem.) [Internet]. 2021 Dec. 5 [cited 2024 Oct. 31];160(3):278-81. Available from: https://www.revistamedicagt.org/index.php/RevMedGuatemala/article/view/393

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)



Copyright notice
   
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated.
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated.
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access).



About the Creative Commons license

Creative Commons Attribution NonCommercial ShareAlike

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)

You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material.
The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:
Attribution Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial NonCommercial — You may not use the material for commercial purposes.
ShareAlike ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.